NYSE American · SRXHConsumer StaplesFood & Tobacco

SRX Global financials

$1.58−7.06%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ3 '26
Jun 30
Q2 '26
Mar 31
Q1 '26
Dec 31
Q4 '25
Sep 30
Q3 '25
Jun 30
Revenue$3.4M$3.4M$2.8M—$2.7M
Gross profit$904.0K$1.3M$1.1M—$31.0K
Gross margin26.7%37.1%37.5%—1.2%
Operating income-$3.2M-$1.8M-$3.8M—-$8.6M
Net income-$4.1M-$6.4M-$8.6M—-$15.1M
Net margin−122.1%−185.5%−306.9%—−566.1%
Diluted EPS$-0.36$-1.20$-15.60—$-44.51
EBITDA-$3.2M-$1.9M-$3.8M-$2.9M-$10.1M
Operating cash flow-$956.0K-$6.6M-$2.9M$7.6M-$1.8M
Free cash flow-$956.0K-$6.6M-$2.9M$7.6M-$1.8M
Diluted shares11.4M5.0M0.6M0.6M0.3M

Balance sheet

Period endJun 30Mar 31Dec 31Sep 30Jun 30
Cash & equivalents$35.2M$20.5M$13.1M$1.3M$912.0K
Short-term investments$13.0M$5.5M$0.00$0.00$0.00
Total debt$0.00$22.6M$21.0M$4.5M$32.0M
Total assets$145.4M$43.4M$27.1M$8.4M$34.0M
Total liabilities$2.4M$25.1M$23.5M$8.0M$79.9M
Shareholders' equity$143.0M$18.3M$3.5M$407.0K-$45.9M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology